Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Jul;28(7):1951-1953.
doi: 10.1681/ASN.2017040443. Epub 2017 Jun 7.

Targeting Plasma Cells with Proteasome Inhibitors: Principles from Primates

E Steve Woodle  1   2 , Simon Tremblay  3   2 , James Driscoll  3   2
Affiliations
Editorial

Targeting Plasma Cells with Proteasome Inhibitors: Principles from Primates

E Steve Woodle et al. J Am Soc Nephrol. 2017 Jul.
No abstract available

Keywords: B cell; HLA antibody; desensitization; plasma cell; proteasome inhibitor.

PubMed Disclaimer

Comment on

References

    1. Tarlinton DM, Hodgkin PD: Targeting plasma cells in autoimmune diseases. J Exp Med 199: 1451–1454, 2004 - PMC - PubMed
    1. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE: The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14: 748–755, 2008 - PubMed
    1. Everly MJ, Everly JJ, Susskind B, Brailey P, Arend LJ, Alloway RR, Roy-Chaudhury P, Govil A, Mogilishetty G, Rike AH, Cardi M, Wadih G, Tevar A, Woodle ES: Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation 86: 1754–1761, 2008 - PubMed
    1. Bontscho J, Schreiber A, Manz RA, Schneider W, Luft FC, Kettritz R: Myeloperoxidase-specific plasma cell depletion by bortezomib protects from anti-neutrophil cytoplasmic autoantibodies-induced glomerulonephritis. J Am Soc Nephrol 22: 336–348, 2011 - PMC - PubMed
    1. Gomez AM, Vrolix K, Martínez-Martínez P, Molenaar PC, Phernambucq M, van der Esch E, Duimel H, Verheyen F, Voll RE, Manz RA, De Baets MH, Losen M: Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis. J Immunol 186: 2503–2513, 2011 - PubMed

LinkOut - more resources